# 바이오스페이스 일일 뉴스 리포트 - 2025년 06월 24일


## 주요 헤드라인

1. **Lilly Takes Victory Lap on Oral Weight Loss Drug as Analysts Spot Safety Crack (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-takes-victory-lap-on-oral-weight-loss-drug-as-analysts-spot-safety-crack>

2. **Lilly Takes Victory Lap on Oral Weight Loss Drug as Analysts Spot Safety Crack (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-takes-victory-lap-on-oral-weight-loss-drug-as-analysts-spot-safety-crack>

3. **Exelixis Beats Bayer in Colorectal Cancer as Zanzalintinib Delivers ‘First Pivotal Success’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/exelixis-beats-bayer-in-colorectal-cancer-as-zanzalintinib-delivers-first-pivotal-success>

4. **Exelixis Beats Bayer in Colorectal Cancer as Zanzalintinib Delivers ‘First Pivotal Success’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/exelixis-beats-bayer-in-colorectal-cancer-as-zanzalintinib-delivers-first-pivotal-success>

5. **Novo Leans on CagriSema’s Safety as Amycretin Moves Forward to Phase III (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/novo-leans-on-cagrisemas-safety-as-amycretin-moves-forward-to-phase-iii>

6. **Compass Plots Path to FDA With ‘Meaningful’ Phase III Data for Psilocybin Drug in Depression (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/compass-plots-path-to-fda-with-meaningful-phase-iii-data-for-psilocybin-drug-in-depression>

7. **Vertex’s Cell Therapy Could Be ‘Functional Cure’ for Diabetes, but Market Prospects Uncertain (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/vertexs-cell-therapy-could-be-functional-cure-for-diabetes-but-market-prospects-uncertain>


---
*2025년 06월 24일 바이오스페이스 뉴스 피드에서 생성된 리포트*